Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Note also that immu had an approval for their indi

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154901
(Total Views: 575)
Posted On: 02/03/2022 4:32:25 PM
Posted By: LaundryMoney
Re: zagnut #117321
Note also that immu had an approval for their indication. So despite how some posts sound like leronlimab has already cured everything, the drug has not proven anything through a phase 3 trial except for HIV. Anything else is an assumption. We don't know Nash 700mg data, We've seen some highlights of mtnbc, but BTD shot down, COVID we speculate that 4 doses will be better than 2, not proven yet. HIV combo is the one we can verifiably say endpoint reached! All other indications a buying firm would need to fit the bill for all the trials and take on all the risk. Now if we had a successful HIV BLA filed and every other indication was just an extension of an already approved drug....we might have something there. Until then, unless all the data we haven't seen is stellar (not just the carefully selected highlights by mgmt in a PR), we aren't going to get top dollar in my humble opinion.

The varied indications does make leronlimab unique so I have no idea what a drug like that in it's infancy stages is worth, but not three figures yet.

One option mgmt could do, and I think ohm mentioned already (sorry if repeat). Present even a low-ball offer to shareholders, which might raise the price enough to sell some of the 200million for funding. Then we can negotiate from an even greater place of strength by getting the drug further developed.


(9)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us